Breast-Feeding May Boost Health of Cancer Survivors
Female childhood cancer survivors should be encouraged to breast-feed as a health behavior that is protective against many late effects of cancer treatment, according to a review published online Jan. 21 in the Journal of Cancer Survivorship.
MONDAY, Feb. 7 (HealthDay News) -- Female childhood cancer survivors should be encouraged to breast-feed as a health behavior that is protective against many late effects of cancer treatment, according to a review published online Jan. 21 in the Journal of Cancer Survivorship.
Susan W. Ogg, R.N., M.S.N., from the St. Jude Children's Research Hospital in Memphis, Tenn., and colleagues reviewed literature on lactation outcomes in female childhood cancer survivors and summarized late effects of cancer treatment on women. They presented the health benefits associated with breast-feeding that might help counter the late effects of cancer treatment on women.
The researchers found that lactation is often compromised among female survivors of childhood cancer. Breast-feeding may ameliorate cancer treatment late effects by improving bone density and decreasing risks of metabolic syndrome, cardiovascular disease, and secondary tumors. Based on these potential benefits, the authors recommend development of interventions to increase breast-feeding among this population.
"Among survivors of childhood cancer whose ability to lactate is intact, breast-feeding should be actively promoted and recommended as a clinically indicated health intervention," the authors write.
AbstractFull Text (subscription or payment may be required)
Related Content
Exogenous hormones and patients at increased risk for breast cancer
October 17th 2023This lecture, presented by Holly J. Pederson, MD, at The Menopause Society 2023 Annual Meeting, looked at combined oral contraceptives in BRCA carriers and other high-risk patients, and hormone therapy in postmenopausal gene carriers as well as other high-risk women.
Read More
Hormone replacement therapy does not increase breast cancer recurrence, mortality in survivors
July 20th 2022An analysis of data from more than 8400 postmenopausal women with a history of early-stage nonmetastatic, ER-positive breast cancer suggests there was no increase in risk of breast cancer recurrence or mortality observed with use of vaginal estrogen therapy or menopausal hormone therapy.
Read More
